You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中国生物制药(01177.HK)"依托考昔片"获药品注册证书
格隆汇 01-04 16:37

格隆汇 1 月 4日丨中国生物制药(01177.HK)公告,集团开发的口服镇痛药"依托考昔片"(商品名:凯昔)(规格:30mg及60mg)已获中华人民共和国国家药品监督管理局颁发药品注册证书,且视同通过仿制药质量和疗效一致性评价。

依托考昔是最新一代的选择性环氧化酶-2(COX-2)抑制剂,具有抗炎、镇痛和解热作用,胃肠道不良反应较小,适用于治疗骨关节炎急性期和慢性期的症状和体征、治疗急性痛风性关节炎和原发性痛经。《美国风湿病学会痛风诊治指南》推荐使用依托考昔于急性痛风性关节炎的治疗。《中国骨关节炎诊治指南》以及中华医学会骨科学分会的《骨科疼痛处理专家意见》推荐有胃肠道风险的患者选用选择性COX-2抑制剂,可使用依托考昔。

该品种的获批将可补充和增强集团在镇痛领域非甾体抗炎药产品线的布局,为广大疼痛患者减轻痛苦并带来治疗上更多的选择。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account